ANchored in work licensed from carnegie Mellon Robtoics Institute, the priimary product developed and offered by Heartlander Surgical Inc is HeartLander -- a miniature mobile robot that delivers minimally invasive therapy to the surface of the beating heart - effectively offering a single device for stable and localized sensing, mapping, and treatment over the entire surface of the heart. Importantly, use of the device reduces the damage necessary to access the heart. Under physician control, the robot: enters the chest through an incision below the sternum (details), adheres to the surface of the heart (details), travels to the desired location (details), and administers the therapy (details)HeartLander is a new medical device, well into pre-clinical development, that enables minimally invasive surgical procedures any place on the surface of a beating heart. HeartLander is placed on the epicardium through a small, sub-xiphoid port. The device is usally understood as walking on the surface of the heart like an inchworm, providing a mobile platform with a stable frame-of-reference relative to the beating heart surface - offering a viable alternative to closed-chest, beating heart endoscopic surgery and endocardial approaches. Lead applications are cardiac ablation and biventricular pacing lead placement.
